在呼吸系统疾病中实施吸入器调节的关键因素:使用修改名义组技术 (NGT) 生成的国际专家共识
Omar S Usmani1, Nicolas Roche2, Job F M van Boven3
1National Heart and Lung Institute, Imperial College London, London, UK.
NPJ primary care respiratory medicine
|February 23, 2026
概括
专家的共识强调优先考虑临床需要和患者参与喘和COPD的吸入器开关. 安全切换需要咨询,同意和教育,而不是成本或环境因素.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 卫生政策 卫生政策
- 患者安全 患者安全
背景情况:
- 在喘和COPD管理中,切换吸入器是常见的.
- 目前的指导方针缺乏安全有效的吸入器转换的全面策略.
- 需要专家的共识来标准化吸入器开关协议.
研究的目的:
- 建立国际专家对最佳吸入器切换实践的共识.
- 定义适当的情况,利益相关者的角色,以及吸入器开关的基本步骤.
- 为临床医生和决策者提供安全有效的吸入器转换信息.
主要方法:
- 国际名义组技术,由八名临床,支付人和患者专家组成.
- 关于吸入器切换驱动器和情况的想法生成和评级.
- 应用决策单位框架用于利益相关者映射.
主要成果:
- 临床和以患者为中心的驱动因素 (例如,疾病控制,技术) 对吸入器开关至关重要.
- 患者安全是首要关注的问题,需要咨询,同意,教育和跟进.
- 成本和环境因素被认为是吸入器切换的最不重要的驱动因素.
结论:
- 吸入器开关应该优先考虑临床需求和患者参与,而不是成本或可持续性.
- 政策制定者必须考虑大规模的吸入器开关实施所涉及的时间和复杂性.
- 制定标准化协议可确保呼吸系统患者的安全有效的吸入器过渡.
相关概念视频
Inhaled Medications
889
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
889
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
COPD: Management Using Bronchodilators and Corticosteroids
907
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
907
Asthma-IV: Nursing Management
3.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.9K
Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K


